Skip to Content
Merck
CN
  • Tau associated peripheral and central neurodegeneration: Identification of an early imaging marker for tauopathy.

Tau associated peripheral and central neurodegeneration: Identification of an early imaging marker for tauopathy.

Neurobiology of disease (2021-01-23)
Alexandra Marquez, Lucie S Guernsey, Katie E Frizzi, Morgan Cundiff, Isabel Constantino, Nabeel Muttalib, Fernanda Arenas, Xiajun Zhou, Sze Hway Lim, Maryam Ferdousi, Georgios Ponirakis, Monty Silverdale, Christopher Kobylecki, Matthew Jones, Andrew Marshall, Rayaz A Malik, Corinne G Jolivalt
ABSTRACT

Pathological hyperphosphorylated tau is a key feature of Alzheimer's disease (AD) and Frontotemporal dementia (FTD). Using transgenic mice overexpressing human non-mutated tau (htau mice), we assessed the contribution of tau to peripheral and central neurodegeneration. Indices of peripheral small and large fiber neuropathy and learning and memory performances were assessed at 3 and 6 months of age. Overexpression of human tau is associated with peripheral neuropathy at 6 months of age. Our study also provides evidence that non-mutated tau hyperphosphorylation plays a critical role in memory deficits. In addition, htau mice had reduced stromal corneal nerve length with preservation of sub-basal corneal nerves, consistent with a somatofugal degeneration. Corneal nerve degeneration occurred prior to any cognitive deficits and peripheral neuropathy. Stromal corneal nerve loss was observed in patients with FTD but not AD. Corneal confocal microscopy may be used to identify early neurodegeneration and differentiate FTD from AD.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Tau phospho Threonine 231 Antibody, Chemicon®, from rabbit
Sigma-Aldrich
Anti-Tau Antibody, a.a. 210-241, clone Tau-5, ascites fluid, clone Tau-5, Chemicon®
Sigma-Aldrich
Anti-Tau phospho Serine 199/202 Antibody, Chemicon®, from rabbit